Medicure Inc.
MPH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.98% | 1.31% | -15.39% | 1.50% | -19.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.98% | 1.31% | -15.39% | 1.50% | -19.88% |
| Cost of Revenue | -11.86% | 69.97% | 20.37% | 13.79% | 38.03% |
| Gross Profit | 41.41% | -24.38% | -30.80% | -4.43% | -45.87% |
| SG&A Expenses | -4.60% | 2.22% | -1.55% | 8.47% | 2.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.79% | 26.36% | 8.87% | 12.34% | 13.05% |
| Operating Income | 69.57% | -1,351.18% | -435.66% | -174.77% | -470.52% |
| Income Before Tax | 73.52% | 762.20% | -440.63% | -72.31% | -464.43% |
| Income Tax Expenses | 384.72% | 28.85% | 63.75% | 342.31% | -115.00% |
| Earnings from Continuing Operations | 65.28% | 696.49% | -572.33% | -82.37% | -440.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.28% | 696.49% | -572.33% | -82.37% | -440.15% |
| EBIT | 69.57% | -1,351.18% | -435.66% | -174.77% | -470.52% |
| EBITDA | 81.22% | -202.50% | -168.81% | -70.50% | -352.93% |
| EPS Basic | 65.23% | 696.67% | -573.33% | -82.69% | -434.36% |
| Normalized Basic EPS | 73.53% | -1,629.41% | -440.85% | -166.17% | -497.16% |
| EPS Diluted | 65.23% | 696.67% | -688.59% | -82.69% | -460.93% |
| Normalized Diluted EPS | 73.53% | -1,777.42% | -443.26% | -166.67% | -504.05% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 1.36% | 1.80% |
| Average Diluted Shares Outstanding | 0.00% | -10.96% | -0.57% | 0.57% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |